ReposiTrak Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

Reuters
20 May
<a href="https://laohu8.com/S/TRAK">ReposiTrak</a> Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

ReposiTrak Inc., the world's largest food traceability and regulatory compliance network, reported a 16% increase in total revenue for the third fiscal quarter of 2025, amounting to $5.9 million compared to $5.1 million in the same quarter of the previous year. The company highlighted that 98% of this revenue was recurring. Operating expenses for the quarter rose by 7% to $4.1 million, up from $3.8 million last year. Net income for the quarter increased by 27% to $2.0 million, compared to $1.6 million in the third quarter of the prior year. Net income to common shareholders also saw a significant rise of 33%, reaching $1.9 million from $1.4 million the previous year. The company reported a diluted earnings per share $(EPS)$ of $0.10, an improvement from $0.08 in the previous year's third fiscal quarter. ReposiTrak also announced that during the quarter, they redeemed 70,093 preferred shares at a redemption price of $10.70 per share, totaling $749,995, and paid $331,000 in cash dividends to common shareholders. The company ended the quarter with over $28.1 million in cash and no bank debt, demonstrating strong financial stability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repositrak Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-017612), on May 19, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10